Pharma and biotech should embrace ‘Medicare for all,’ not defeat it
JIM WATSON/AFP/GETTY IMAGES
Genetic research, and the effective but costly therapies emerging from it, will make Medicare for all, or something like it, all but inevitable.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario